Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
High-Resolution Rapid Microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Schwannomatosis Panel on Tumor Block Medical Genomics Laboratory Department of Genetics UAB United States | 2 | 3 |
|
Neurofibromatosis Type 2 (NF2) Next Genetration Sequencing and Deletion/Duplication Testing Medical Genomics Laboratory Department of Genetics UAB United States | 1 | 1 |
|
Rapid microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
NF2-related Schwannomatosis Comprehensive Testing from Paraffin Embedded Biopsy Specimen Medical Genomics Laboratory Department of Genetics UAB United States | 1 | 1 |
|
FAMILIAL SCHWANNOMATOSI - SMARCB1/INI1 gene Clinical Genomics Unit Hospital Universitari Germans Trias i Pujol Spain | 2 | 3 |
|
NEUROFIBROMATOSI DE TYPE 2 - NF2 gene Clinical Genomics Unit Hospital Universitari Germans Trias i Pujol Spain | 3 | 3 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
NF2 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 3 | 1 |
|
Centogene US, LLC - The Rare Disease Company United States | 3 | 1 |
|
Centogene US, LLC - The Rare Disease Company United States | 156 | 107 |
|
Centogene US, LLC - The Rare Disease Company United States | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
NF2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.